These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

100 related articles for article (PubMed ID: 386157)

  • 41. Developing ways of reducing allograft immunogenicity.
    Guttmann RD
    Can Med Assoc J; 1981 Jan; 124(2):143-5. PubMed ID: 7006782
    [No Abstract]   [Full Text] [Related]  

  • 42. The effect of donor pretreatment and low-dose immunosuppression on the 24-hour preserved canine renal allograft.
    Swistel AJ; McCabe RE; Lorieo DR; Wildstein A; Fitzpatrick HF
    Transplant Proc; 1979 Sep; 11(3):1673-5. PubMed ID: 388773
    [No Abstract]   [Full Text] [Related]  

  • 43. Failure of blood transfusions to improve cadaveric renal allograft survival.
    Jeffery JR; Downs A; Grahame JW; Lye C; Ramsey E; Thomson AE
    Transplantation; 1978 Jun; 25(6):344-5. PubMed ID: 351896
    [No Abstract]   [Full Text] [Related]  

  • 44. The UNOS scientific renal transplant registry. United Network for Organ Sharing.
    Cecka JM; Terasaki PI
    Clin Transpl; 1995; ():1-18. PubMed ID: 8794251
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Effect of high doses of intravenous methylprednisolone and cyclophosphamide on renal homografts.
    Zincke H; Woods JE; Holley KE
    Urology; 1977 Oct; 10(4):301-4. PubMed ID: 335605
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Effect of positive crossmatch against donor B lymphocytes in kidney transplantation: a prospective one-center study.
    Hourmant M; Bignon JD; Cesbron A; Soulillou JP
    Clin Transpl; 1990; ():301-9. PubMed ID: 2103154
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Update of the University of California at San Francisco experience with donor-specific blood transfusions.
    Salvatierra O; Iwaki Y; Vincenti F; Amend W; Terasaki P; Garovoy M; Duca R; Hopper S; Feduska N
    Transplant Proc; 1982 Jun; 14(2):363-6. PubMed ID: 7051480
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Renal transplantation from donors aged < 6 years into children yields equal graft survival when compared to older donors.
    Filler G; Lindeke A; Böhme K; Devaux S; Schönberger B; Ehrich JH
    Pediatr Transplant; 1997 Nov; 1(2):119-23. PubMed ID: 10084771
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Donor factors in cadaveric renal transplantation.
    Feduska NJ
    Clin Transpl; 1993; ():351-7. PubMed ID: 7918168
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Cadaver versus living donor kidneys: impact of donor factors on antigen induction before transplantation.
    Koo DD; Welsh KI; McLaren AJ; Roake JA; Morris PJ; Fuggle SV
    Kidney Int; 1999 Oct; 56(4):1551-9. PubMed ID: 10504507
    [TBL] [Abstract][Full Text] [Related]  

  • 51. High survival rates of kidney transplants from spousal and living unrelated donors.
    Terasaki PI; Cecka JM; Gjertson DW; Takemoto S
    N Engl J Med; 1995 Aug; 333(6):333-6. PubMed ID: 7609748
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Improved survival of heart transplants. Graft and/or donor pretreatment with antilymphoblast globulin, cyclophosphamide, or methylprednisolone.
    Toledo-Pereyra LH; Condie RM
    J Thorac Cardiovasc Surg; 1978 Apr; 75(4):536-41. PubMed ID: 347179
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Donor and donor organ pretreatment in cardiac allografts.
    Todd GJ; Nowygrod R; Hardy MA; Reemtsma K
    Surg Forum; 1978; 29():362-4. PubMed ID: 401189
    [No Abstract]   [Full Text] [Related]  

  • 54. Significance of the donor age effect on kidney transplants.
    Terasaki PI; Gjertson DW; Cecka JM; Takemoto S; Cho YW
    Clin Transplant; 1997 Oct; 11(5 Pt 1):366-72. PubMed ID: 9361925
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Low-dose steroid therapy in cyclosporine-treated renal transplant recipients with well-functioning grafts. The Canadian Multicentre Transplant Study Group.
    Sinclair NR
    CMAJ; 1992 Sep; 147(5):645-57. PubMed ID: 1521210
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Impact of pre-existing donor hypertension and diabetes mellitus on cadaveric renal transplant outcomes.
    Ojo AO; Leichtman AB; Punch JD; Hanson JA; Dickinson DM; Wolfe RA; Port FK; Agodoa LY
    Am J Kidney Dis; 2000 Jul; 36(1):153-9. PubMed ID: 10873885
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Renal transplantation in the UK and Republic of Ireland.
    Johnson RJ; Belger MA; Briggs JD; Fuggle SV; Morris PJ;
    Clin Transpl; 2000; ():105-13. PubMed ID: 11512304
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Donor factors.
    Cecka JM
    Clin Transpl; 1987; ():423-34. PubMed ID: 3154442
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Renal transplantation in cyclosporine-treated recipients at the Singapore General Hospital.
    Vathsala A; Woo KT
    Clin Transpl; 1999; ():189-97. PubMed ID: 11038637
    [TBL] [Abstract][Full Text] [Related]  

  • 60. The UNOS Renal Transplant Registry.
    Cecka JM
    Clin Transpl; 2002; ():1-20. PubMed ID: 12971433
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.